Cincinnati Children’s participates in clinical trials organized by the International Histiocyte Society involving hemophagocytic lymphohistiocytosis (HLH) and Langerhans cell histiocytosis (LCH).
All patients who are evaluated and diagnosed with an immune deficiency are offered the opportunity to participate in the Immunodeficiency Registry; as a part of this registry, blood may be stored for genetic testing or shared with scientists around the world who investigate a variety of immune deficiencies.
Laboratory researchers in the Cancer and Blood Diseases Institute work together with physicians to translate breakthroughs from the lab to the clinic. And many of our physician-researchers hold leadership positions in national cooperative groups that bring Phase I clinical trials to medical centers around the country.
Many of the trials we offer are available at only a few institutions in the United States, and others are not available anywhere else.
Featured Clinical Trials for Immune Deficiency and Histiocytosis